Clinical trial
Topical Imiquimod 5% Cream in the Treatment of Nodular Basal Cell Carcinoma After Initial Treatment With Curettage
NCT00314756 is registered in ClinicalTrials.gov with Wake Forest University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Topical Imiquimod 5% Cream in the Treatment of Nodular Basal Cell Carcinoma After Initial Treatment With Curettage
- Lead sponsor
- Wake Forest University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2005
- Completion date
- November 30, 2005
- Enrollment
- 15
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.